title: Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
authors.forename: Serge
authors.initials: S
authors.lastname: Friedman
authors.forename: Tania Abou
authors.initials: TA
authors.lastname: Abdallah
authors.forename: Mohamed
authors.initials: M
authors.lastname: Oumaya
authors.forename: Frédéric
authors.initials: F
authors.lastname: Rouillon
authors.forename: Julien-Daniel
authors.initials: JD
authors.lastname: Guelfi
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D002997:Clomipramine / Q000494:pharmacology / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D000068180:Aripiprazole; D002997:Clomipramine; D010879:Piperazines; D015363:Quinolones; D017367:Selective Serotonin Reuptake Inhibitors